Filing Details
- Accession Number:
- 0001061983-21-000255
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-11-09 17:35:14
- Reporting Period:
- 2021-11-09
- Accepted Time:
- 2021-11-09 17:35:14
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1061983 | Cytokinetics Inc | CYTK | Pharmaceutical Preparations (2834) | 943291317 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1316459 | David Cragg | 280 East Grand Avenue South San Francisco CA 94080 | Chief Hr & Admin Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-11-09 | 24,519 | $9.65 | 163,223 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-11-09 | 24,519 | $41.76 | 138,704 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2021-11-09 | 20,481 | $9.65 | 159,185 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-11-09 | 20,481 | $41.76 | 138,704 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Incentive Stock Option (right to buy) | Disposition | 2021-11-09 | 20,481 | $0.00 | 20,481 | $9.65 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2021-11-09 | 24,519 | $0.00 | 24,519 | $9.65 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2014-03-24 | 2024-02-24 | No | 4 | M | Direct |
| 0 | 2014-03-24 | 2024-02-24 | No | 4 | M | Direct |
Footnotes
- Includes up to 13,678 shares of common stock purchased pursuant to the Cytokinetics, Incorporated Employee Stock Purchase Plan.
Billionaire Hedge Funds
